Effects of amiodarone on thyroid function

被引:213
作者
Harjai, KJ
Licata, AA
机构
[1] CLEVELAND CLIN FDN, DEPT ENDOCRINOL, CLEVELAND, OH 44195 USA
[2] ALTON OCHSNER MED FDN & OCHSNER CLIN, NEW ORLEANS, LA 70121 USA
关键词
D O I
10.7326/0003-4819-126-1-199701010-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To review the literature on the effects of amiodarone on thyroid physiology and management of amiodarone-induced thyroid disease. Data Sources: English-language articles identified through a MEDLINE search (for 1975 to 1995, using the terms amiodarone and thyroid) and selected cross-referenced articles. Study Selection: Articles on the effects of amiodarone on thyroid physiology and function tests and occurrence, recognition, and management of amiodarone-induced thyroid disease. Data Extraction: Data were manually extracted from selected studies and reports; emphasis was placed on information relevant to the practicing clinician. Data Synthesis: Amiodarone can have many effects on thyroid function test results, even in the absence of hyperthyroidism or hypothyroidism. It may cause an increase in serum levels of thyroxine, reverse triiodothyronine, and thyroid-stimulating hormone and a decrease in serum triiodothyronine levels. Thyrotoxicosis occurs in some patients and is related to several pathogenetic mechanisms. It often presents dramatically with obvious clinical manifestations and further changes in thyroid function test results. Medical options include therapy with thionamides, perchlorate, and prednisone. Radioactive iodine is of little use. Thyroidectomy is effective and is the only measure that consistently allows continued use of amiodarone. Unlike thyrotoxicosis, hypothyroidism is related to a persi stent Wolff-Chaikoff effect and often has a vague presentation. The goal of treatment of amiodarone-induced hypothyroidism is to bring serum thyroxine levels to the upper end of the normal range, as often seen in euthyroid patients who are receiving amiodarone. Conclusions: Thyroid dysfunction commonly occurs with amiodarone therapy. It may be difficult to recognize the dysfunction because of the many changes in thyroid function test results that occur in euthyroid patients who are receiving amiodarone. Effective strategies exist for the management of hyperthyroidism and hypothyroidism; these should be tailored to the needs of the individual patient.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 118 条
[1]   AMIODARONE INHIBITS THE CONVERSION OF THYROXINE TO TRIIODOTHYRONINE IN ISOLATED RAT HEPATOCYTES [J].
AANDERUD, S ;
SUNDSFJORD, J ;
AARBAKKE, J .
ENDOCRINOLOGY, 1984, 115 (04) :1605-1608
[2]   THYROID-DYSFUNCTION DURING CHRONIC AMIODARONE THERAPY [J].
ALBERT, SG ;
ALVES, LE ;
ROSE, EP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (01) :175-184
[3]   CUTANEOUS HYPERPIGMENTATION INDUCED BY AMIODARONE HYDROCHLORIDE [J].
ALINOVI, A ;
REVERBERI, C ;
MELISSARI, M ;
GABRIELLI, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1985, 12 (03) :563-566
[4]  
ALTHAUS B, 1988, SCHWEIZ MED WSCHR, V118, P1176
[5]   AMIODARONE AND THE THYROID [J].
ALVES, LE ;
ROSE, EP ;
CAHILL, TB .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) :412-412
[6]   CLINICAL AND CHEMICAL ASSESSMENT OF THYROID-FUNCTION DURING THERAPY WITH AMIODARONE [J].
AMICO, JA ;
RICHARDSON, V ;
ALPERT, B ;
KLEIN, I .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (03) :487-490
[7]   THE CORRELATION OF SERUM AMIODARONE LEVELS WITH ABNORMALITIES IN THE METABOLISM OF THYROXINE [J].
ANASTASIOUNANA, M ;
KOUTRAS, DA ;
LEVIS, G ;
SOUVATZOGLOU, A ;
BOUKIS, MA ;
MOULOPOULOS, SD .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1984, 7 (04) :405-407
[8]  
[Anonymous], 1987, LANCET, V2, P24
[9]   SERUM SEX HORMONE-BINDING GLOBULIN IN AMIODARONE-TREATED PATIENTS [J].
BAMBINI, G ;
AGHINILOMBARDI, F ;
ROSNER, W ;
KHAN, MS ;
MARTINO, E ;
PINCHERA, A ;
BRAVERMAN, LE ;
SAFRAN, M .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (10) :1781-1785
[10]   SERUM INTERLEUKIN-6 IN AMIODARONE-INDUCED THYROTOXICOSIS [J].
BARTALENA, L ;
GRASSO, L ;
BROGIONI, S ;
AGHINILOMBARDI, F ;
BRAVERMAN, LE ;
MARTINO, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) :423-427